Fordyce Marshall

PRESIDENT AND CEO

Fordyce Marshall has filed 11 SEC Form 4 filings (28 transaction rows) across 1 company, with disclosures dating back to 2026. 11 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.

On the most recent filing, Fordyce Marshall is listed as PRESIDENT AND CEO at Vera Therapeutics, Inc. Inside the rolling window, Fordyce Marshall reported no open-market purchases and 7 open-market sales totaling $6.4M in VERA. The largest disclosed transaction in the window is a sale of 46,250 VERA shares on Jul 7, 2026, worth $2.0M.

Companies traded

Other insiders at VERA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
VERASale$685KSep 17SEC ↗
VERASale$650KSep 4SEC ↗
VERASale$2.0MAug 12SEC ↗
VERASale$702KAug 12SEC ↗
VERASale$680KAug 12SEC ↗
VERASale$1.0MApr 15SEC ↗
VERASale$711KFeb 25SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Fordyce Marshall made?

Fordyce Marshall has filed 11 SEC Form 4 filings (28 transaction rows) across 1 company since 2026.

Which companies does Fordyce Marshall trade?

Fordyce Marshall has filed SEC Form 4 disclosures for 1 company, including VERA.

When was Fordyce Marshall's most recent SEC Form 4 filing?

Fordyce Marshall's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.

What is Fordyce Marshall's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Fordyce Marshall is listed as PRESIDENT AND CEO.

What is Fordyce Marshall's total buy and sell value in the current window?

Inside the rolling retention window, Fordyce Marshall bought $0 and sold $6.4M based on SEC Form 4 filings.

What was Fordyce Marshall's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 46,250 VERA shares on 2026-07-07, worth $2.0M, per SEC Form 4 filings.